NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research report report published on Tuesday. The firm issued a hold rating on the stock. NovaBay Pharmaceuticals Price Performance NBY stock opened at $0.61 on Tuesday. The company has a 50 day moving average price of $0.65 and a 200 day […]
